Recomendaciones para el uso de biomarcadores en el paciente con COVID-19. Primera parte

Rosana Andrea Raimondi; Gabriela Quattrocchi; Graciela Beatriz Jacquier

doi:10.62073/bypc.v85i3.189

Vol. 85 No. 3 (2021), Guía de Recomendación

Vol. 85 No. 3 (2021)

Recommendations for the use of biomarkers in COVID-19 patients. First part

Guía de Recomendación

Published 2021-08-27

Rosana Andrea Raimondi⁺⁻
Gabriela Quattrocchi⁺⁻
Graciela Beatriz Jacquier⁺⁻

Rosana Andrea Raimondi

Sección Urgencias, Laboratorio Central, Departamento de Diagnóstico y Tratamiento, Hospital General de Agudos Carlos Durand. Ciudad Autónoma de Buenos Aires, Argentina.

Gabriela Quattrocchi

Sección Urgencias, Laboratorio Central, Departamento de Diagnóstico y Tratamiento, Hospital General de Agudos Ignacio Pirovano. Ciudad Autónoma de Buenos Aires, Argentina.

Graciela Beatriz Jacquier

Sección Urgencias, Laboratorio Central, Departamento de Diagnóstico y Tratamiento, Hospital General de Agudos José María Penna. Ciudad Autónoma de Buenos Aires, Argentina.

PDF (Spanish)

HTML (Spanish)

Keywords

SARS-CoV-2
COVID-19
D-dimer
procalcitonin
biomarkers

How to Cite

Recommendations for the use of biomarkers in COVID-19 patients. First part. (2021). Biochemistry and Clinical Pathology Journal, 85(3), 51-57. https://doi.org/10.62073/bypc.v85i3.189

Abstract

The infection caused by SARS-CoV-2 affects the structure of different organs such as the heart, kidney and lungs. This damage can be detected by means of clinical laboratory tests. The present work is a bibliographic review that attempts to provide biochemists with an update of the characteristics of the biomarkers D-Dimer and procalcitonin, their diagnostic methods and clinical utility, both in the diagnosis and follow-up of COVID-19 patients.